Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed at $4.60 down -17.27% from its previous closing price of $5.56. In other words, the price has decreased by -$17.27 from its previous closing price. On the day, 1.63 million shares were traded.
Ratios:
For a deeper understanding of Olema Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 08 ’25 when Bain Capital Life Sciences Inv bought 300,000 shares for $5.76 per share. The transaction valued at 1,727,370 led to the insider holds 7,800,000 shares of the business.
Graham G. Walmsley sold 700,761 shares of OLMA for $4,730,137 on Dec 17 ’24. The Director now owns 0 shares after completing the transaction at $6.75 per share. On Dec 13 ’24, another insider, Logos Opportunities Fund I LP, who serves as the Affiliate of the company, bought 700,761 shares for $6.75 each.
Stock Price History:
Over the past 52 weeks, OLMA has reached a high of $16.62, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 6.83%, while the 200-Day Moving Average is calculated to be -46.15%.
Shares Statistics:
A total of 74.31M shares are outstanding, with a floating share count of 54.65M. Insiders hold about 20.05% of the company’s shares, while institutions hold 84.42% stake in the company.
Earnings Estimates
The stock of Olema Pharmaceuticals Inc (OLMA) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.4 and low estimates of -$0.7.
Analysts are recommending an EPS of between -$1.61 and -$3.03 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$2.34, with 6.0 analysts recommending between -$1.68 and -$3.86.
